3.0
8. Dez. 2022
Aktueller Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good oncology experience. Good experience with other aspects of trial and resources to learn. Provide health benefits and stock shares.
Kontras
Salary not as competitive as other pharmas HR is backwards. Too many new hires but lack of process. Not sure how much interest the managers have for your growth.